The article examines the technological order (ETEC) as a legal and strategic instrument for innovation in public health, based on the agreement signed between AstraZeneca and the Institute of Technology in Immunobiologicals (Bio-Manguinhos), a production unit of the Oswaldo Cruz Foundation (Fiocruz), for the manufacture of the Covid-19 vaccine. The research was structured into a literature review and a detailed case study. The findings, systematized through content analysis, demonstrated the potential of the technological order as an instrument of innovation by enabling technology transfer and the national production of vaccines within a short timeframe. Despite legal and contractual challenges, the initiative strengthened Brazil’s national capacity to respond to crises by ensuring rapid access to the vaccine, while also fostering technological autonomy and reinforcing institutional capacities for innovation in public health.